Immunization against Haemophilus influenzae type b in Iran; Cost-utility and cost-benefit analyses

MLA

Maziar Moradi-Lakeh, et al. “Immunization against Haemophilus Influenzae Type b in Iran; Cost-Utility and Cost-Benefit Analyses.” International Journal of Preventive Medicine, vol. 3, no. 5, Jan. 2012, pp. 332–40. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....a3994066f0ca4c90bf9db6d079ae6cbf&authtype=sso&custid=ns315887.

APA

Maziar Moradi-Lakeh, Shakerian, S., & Esteghamati, A. (2012). Immunization against Haemophilus influenzae type b in Iran; Cost-utility and cost-benefit analyses. International Journal of Preventive Medicine, 3(5), 332–340.

Chicago

Maziar Moradi-Lakeh, S. Shakerian, and A. Esteghamati. 2012. “Immunization against Haemophilus Influenzae Type b in Iran; Cost-Utility and Cost-Benefit Analyses.” International Journal of Preventive Medicine 3 (5): 332–40. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....a3994066f0ca4c90bf9db6d079ae6cbf&authtype=sso&custid=ns315887.